John F. Sheridan
2019
Compensation breakdown
Non-Equity Incentive Plan | $738,225 |
---|---|
Option Awards | $9,319,134 |
Salary | $500,000 |
Other | $3,578 |
Total | $10,560,937 |
Sheridan received $9.3M in option awards, accounting for 88% of the total pay in 2019.
Sheridan also received $738.2K in non-equity incentive plan, $500K in salary and $3.6K in other compensation.
Rankings
In 2019, John F. Sheridan's compensation ranked 676th out of 13,971 executives tracked by ExecPay. In other words, Sheridan earned more than 95.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 676 | 95th |
Manufacturing | 236 | 96th |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 28 | 97th |
Surgical, Medical, And Dental Instruments And Supplies | 14 | 97th |
Surgical and Medical Instruments and Apparatus | 7 | 98th |
Pay ratio
John F. Sheridan's Pay | $10,560,937 |
---|---|
Median Employee's Pay | $105,295 |
Pay Ratio | 100to 1 |
In 2019, the annual total compensation of John F. Sheridan was $10,560,937.
The annual total compensation of the median employee at Tandem Diabetes Care was $105,295.
The ratio of John F. Sheridan's pay to the pay of median employee was therefore 100 to one.
Sheridan's colleagues
We found five more compensation records of executives who worked with John F. Sheridan at Tandem Diabetes Care in 2019.
2019
Kim Blickenstaff
Tandem Diabetes Care
Chief Executive Officer
2019
Brian Hansen
Tandem Diabetes Care
Executive Vice President, Chief Commercial Officer
2019
Leigh Vosseller
Tandem Diabetes Care
Chief Financial Officer
2019
David Berger
Tandem Diabetes Care
Secretary
2019
Susan Morrison
Tandem Diabetes Care